Aimee deCathelineau is currently the SVP, Medical Director, Medical Strategy & Scientific Affairs at BGB Group since March 2020. Prior to that, Aimee held the position of VP, Medical Director at BioNYC (a division of BGB Group) from August 2015 to March 2020. With experience dating back to February 2011, Aimee has also worked as Vice President, Medical Director at Virtuoso Healthcare Communications. Aimee completed a Doctor of Philosophy - PhD in Experimental Pathology at The University of Colorado Health Sciences Center from 1998 to 2003.
October, 2021 - present
March, 2020